O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+12.61%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11B
AUM Growth
+$11B
(+12%)
Cap. Flow
+$293M
Cap. Flow
% of AUM
2.65%
Top 10 Holdings %
Top 10 Hldgs %
40.32%
Holding
136
New
6
Increased
34
Reduced
26
Closed
7
Top Buys
| 1 |
Viatris
VTRS
|
$171M |
| 2 |
Gilead Sciences
GILD
|
$125M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$96.4M |
| 4 |
Puma Biotechnology
PBYI
|
$81.8M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$73.4M |
Top Sells
| 1 |
Molina Healthcare
MOH
|
$160M |
| 2 |
SHPG
Shire pic
SHPG
|
$84.8M |
| 3 |
Neurocrine Biosciences
NBIX
|
$73.6M |
| 4 |
McKesson
MCK
|
$69.2M |
| 5 |
Illumina
ILMN
|
$52.6M |
Sector Composition
| 1 | Healthcare | 90.59% |
| 2 | Financials | 0.18% |
| 3 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $577M | 5.23% | 8,395,000 -273,100 | -3% | -$18.8M |
|
2
Amgen
AMGN
$155B
| $474M | 4.29% | 2,921,000 -92,000 | -3% | -$14.9M |
|
3
Boston Scientific
BSX
$156B
| $451M | 4.08% | 24,430,900 +423,700 | +2% | +$7.81M |
|
|
AGN
4
DELISTED
Allergan plc
AGN
| $445M | 4.03% | 1,424,715 -18,600 | -1% | -$5.81M |
|
5
Biogen
BIIB
$19.4B
| $442M | 4% | 1,442,500 +135,100 | +10% | +$41.4M |
|
6
AbbVie
ABBV
$372B
| $441M | 4% | 7,448,500 +505,300 | +7% | +$29.9M |
|
|
CELG
7
DELISTED
Celgene Corp
CELG
| $439M | 3.98% | 3,665,450 +72,450 | +2% | +$8.68M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $434M | 3.93% | 2,275,100 +48,500 | +2% | +$9.25M |
|
9
HCA Healthcare
HCA
$94.5B
| $403M | 3.65% | 5,955,600 +117,700 | +2% | +$7.96M |
|
|
10
Gilead Sciences
GILD
$140B
| $346M | 3.14% | 3,421,400 +1,237,000 | +57% | +$125M |
|
11
Incyte
INCY
$16.5B
| $307M | 2.78% | 2,832,978 +92,000 | +3% | +$9.98M |
|
|
IPXL
12
DELISTED
Impax Laboratories, Inc.
IPXL
| $285M | 2.58% | 6,664,100 | – | – |
|
13
Regeneron Pharmaceuticals
REGN
$61.5B
| $262M | 2.37% | 483,000 -4,700 | -1% | -$2.55M |
|
|
RLYP
14
DELISTED
RELYPSA INC COM
RLYP
| $210M | 1.9% | 7,400,000 | – | – |
|
|
HNT
15
DELISTED
HEALTH NET INC
HNT
| $205M | 1.85% | 2,988,800 -409,000 | -12% | -$28M |
|
|
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
| $199M | 1.81% | 8,245,111 +103,111 | +1% | +$2.49M |
|
17
Thermo Fisher Scientific
TMO
$186B
| $196M | 1.77% | 1,380,000 +16,000 | +1% | +$2.27M |
|
|
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
| $191M | 1.73% | 2,182,000 +840,000 | +63% | +$73.4M |
|
|
19
Puma Biotechnology
PBYI
$254M
| $176M | 1.59% | 2,238,825 +1,043,325 | +87% | +$81.8M |
|
|
20
Viatris
VTRS
$12.3B
| $171M | 1.55% | +3,157,000 | New | +$171M |
|
|
21
Illumina
ILMN
$15.8B
| $168M | 1.52% | 877,000 -274,000 | -24% | -$52.6M |
|
|
ICPT
22
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $167M | 1.51% | 1,120,000 | – | – |
|
23
Teva Pharmaceuticals
TEVA
$21.1B
| $161M | 1.45% | 2,446,000 +247,000 | +11% | +$16.2M |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $158M | 1.43% | 2,011,500 +88,000 | +5% | +$6.91M |
|
|
25
Neurocrine Biosciences
NBIX
$13.8B
| $142M | 1.29% | 2,514,974 -1,301,076 | -34% | -$73.6M |
|